California is preparing to enforce limits on health care spending growth, creating a financial test for hospitals already dealing with higher labor, drug and operating costs.
The California Office of Health Care Affordability has adopted an enforcement framework for hospitals, physician groups and insurers that exceed state spending targets.
The statewide target is 3.5% for 2025 and 2026. It falls to 3.2% in 2027 and 2028, then to 3% in 2029.
Seven hospitals classified by the state as high cost face tighter targets. Washington Health in Fremont, for example, has a 1.8% spending growth target for 2026. That falls to 1.6% in 2029.
The enforcement framework allows regulators to impose penalties ranging from 0% to 125% of spending above the applicable target. The first financial penalties could be issued in 2028.
The policy raises the stakes for health systems. California is moving beyond tracking health care spending growth and asking providers to explain higher costs. The state is building a system that can impose financial penalties when organizations repeatedly fail to meet spending targets.
That puts hospital spending decisions under greater scrutiny at a time when many health systems say some of their fastest-growing expenses are difficult to control.
California is giving its spending targets more financial weight
California created the Office of Health Care Affordability in 2022 as part of a broader effort to slow rising health care costs. The new enforcement framework gives that effort stronger consequences.
Health care spending in the state increased by an average of about 6% a year during the past decade, according to figures reported by CalMatters. The state’s 3.5% target therefore calls for growth well below the recent historical rate.
Hospitals that exceed the target will not automatically receive a financial penalty.
State officials plan to use a progressive enforcement process. Organizations that miss their targets can first receive technical assistance. They may then be required to complete a performance improvement plan aimed at bringing future spending growth closer to the state’s target.
Financial penalties are intended for organizations that fail to comply with those plans. Regulators will have discretion when setting the size of a penalty, with fines ranging from zero to 125% of the amount spent above the target.
That distinction matters for hospital leaders. The policy is designed to influence spending decisions before a fine is issued instead of relying only on penalties after costs have risen.
It could affect decisions on staffing, supplier contracts, capital spending and service expansion. Health systems may need to show why spending increased and what they did to keep growth within the state’s limits.
The 3.5% figure also should not be viewed as a simple cap on a hospital’s entire budget. It is a spending growth target within a wider regulatory process.
Still, the potential financial consequences give California’s model more force than benchmark programs that rely mainly on reporting and public pressure.
Hospitals say major cost pressures cannot always be controlled
The central problem for providers is the gap between a spending growth target and the actual cost of operating a hospital.
Hospital executives have argued that they have limited control over several major expenses. These include pharmaceutical prices, wages and other market costs. California hospitals also face state requirements that can require large investments in buildings and earthquake safety.
The California Hospital Association has challenged the hospital spending targets in court. The association has argued that the state’s approach could affect patients and the availability of hospital services.
Insurers have also raised questions about the framework. The California Association of Health Plans has said regulators need to distinguish between spending growth organizations can address and increases caused by wider market or policy conditions.
That issue may become more important as targets fall.
A hospital facing a target below 2%, for example, could struggle to remain within it if wages, drugs or other major inputs increase at a faster rate. Management could then have to find savings elsewhere or explain to regulators why higher spending was difficult to avoid.
For executives, this changes the role of cost control. Annual budgeting will increasingly sit alongside regulatory exposure. Investments that increase spending may require stronger evidence that they improve efficiency, access or patient care over time.
There is also a wider policy question. A spending target can pressure organizations to operate more efficiently, but the effect depends on where savings are made. Reducing administrative costs carries different consequences from cutting clinical capacity or delaying capital investment.
How California applies its enforcement powers may therefore matter as much as the headline targets.
California could test whether stronger enforcement changes spending
California’s policy comes as new research raises questions about whether state spending benchmarks have worked elsewhere.
A study published in JAMA Network Open in February 2026 examined state health care spending benchmark programs. It found no statistically significant association between those programs and lower hospital inpatient revenue, outpatient revenue, inpatient prices or outpatient prices. Researchers also found mixed effects on insurance premiums.
The researchers said spending benchmarks may require stricter enforcement or other policies, including price caps or reference pricing, to produce measurable results.
An accompanying commentary noted that eight states had adopted spending benchmarks. It argued that programs backed by stronger enforcement have historically had more success controlling hospital costs than voluntary systems.
California will now provide another test of that approach.
Its system includes spending targets, performance improvement plans and penalties that can exceed the amount an organization spends above its target. That gives regulators more options than public reporting alone.
Stronger enforcement, however, does not settle the main policy questions. Regulators still need to decide when excess spending reflects management decisions and when it reflects outside costs. Hospitals will need to show where their money is going and what steps they have taken to control expenses.
The results could matter beyond California.
Other states considering ways to slow health care spending may watch whether a tighter enforcement model reduces spending growth without adding pressure to access or hospital finances.
For health system leaders, spending growth is becoming more than an internal finance measure. In California, it is also becoming a regulatory measure.
Source
